2172 — MicroPort NeuroScientic Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for MicroPort NeuroScientic, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	51.4	31.9	-4.33	162	303
Depreciation
Non-Cash Items	4.22	40	135	55.5	21.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-20.9	53.8	36	-120	-98.4
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	47.2	157	224	154	284
Capital Expenditures	-34.1	-58	-47.9	-203	-56.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-38.9	-129	-297	-30.6	-104
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-73	-187	-345	-233	-161
Financing Cash Flow Items	148	-115	79	-0.93	0.384
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	432	201	330	-33.3	-226
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	403	168	235	-107	-98.6